These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24510836)

  • 1. DNA electroporation of multi-agent vaccines conferring protection against select agent challenge: TriGrid delivery system.
    Keane-Myers AM; Bell M; Hannaman D; Albrecht M
    Methods Mol Biol; 2014; 1121():325-36. PubMed ID: 24510836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague.
    Albrecht MT; Livingston BD; Pesce JT; Bell MG; Hannaman D; Keane-Myers AM
    Vaccine; 2012 Jul; 30(32):4872-83. PubMed ID: 22633906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model.
    Shen X; Söderholm J; Lin F; Kobinger G; Bello A; Gregg DA; Broderick KE; Sardesai NY
    Vaccine; 2012 Nov; 30(48):6946-54. PubMed ID: 22406460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months.
    Tsang C; Babiuk S; van Drunen Littel-van den Hurk S; Babiuk LA; Griebel P
    Vaccine; 2007 Jul; 25(30):5485-94. PubMed ID: 17408815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of electroporated DNA vaccines.
    Keane-Myers AM; Bell M
    Methods Mol Biol; 2014; 1121():269-78. PubMed ID: 24510831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
    McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2014; 10(10):3039-47. PubMed ID: 25483486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine.
    Wu CJ; Lee SC; Huang HW; Tao MH
    Vaccine; 2004 Mar; 22(11-12):1457-64. PubMed ID: 15063569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
    McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2015; 11(3):746-54. PubMed ID: 25839221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early events of electroporation-mediated intramuscular DNA vaccination potentiate Th1-directed immune responses.
    Grønevik E; Mathiesen I; Lømo T
    J Gene Med; 2005 Sep; 7(9):1246-54. PubMed ID: 15822067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation.
    Dobaño C; Widera G; Rabussay D; Doolan DL
    Vaccine; 2007 Sep; 25(36):6635-45. PubMed ID: 17669562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroporation-mediated administration of candidate DNA vaccines against HIV-1.
    Vasan S
    Methods Mol Biol; 2014; 1121():291-307. PubMed ID: 24510833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electroporation at low voltages enables DNA vaccine to provide protection against a lethal H5N1 avian influenza virus challenge in mice.
    Zhou Y; Fang F; Chen J; Wang H; Chang H; Yang Z; Chen Z
    Intervirology; 2008; 51(4):241-6. PubMed ID: 18812697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo electroporation enhances immunogenicity and protection against influenza A virus challenge of an M2e-HSP70c DNA vaccine.
    Jazi MH; Dabaghian M; Tebianian M; Gharagozlou MJ; Ebrahimi SM
    Virus Res; 2012 Aug; 167(2):219-25. PubMed ID: 22609252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccination in skin enhanced by electroporation.
    Broderick KE; Khan AS; Sardesai NY
    Methods Mol Biol; 2014; 1143():123-30. PubMed ID: 24715285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
    Bråve A; Hallengärd D; Gudmundsdotter L; Stout R; Walters R; Wahren B; Hallermalm K
    Vaccine; 2009 Jun; 27(28):3692-6. PubMed ID: 19428161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo plasmid electroporation induces tumor antigen-specific CD8+ T-cell responses and delays tumor growth in a syngeneic mouse melanoma model.
    Kalat M; Küpcü Z; Schüller S; Zalusky D; Zehetner M; Paster W; Schweighoffer T
    Cancer Res; 2002 Oct; 62(19):5489-94. PubMed ID: 12359758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroporation-mediated intradermal delivery of DNA vaccines in nonhuman primates.
    Adam L; Le Grand R; Martinon F
    Methods Mol Biol; 2014; 1121():309-13. PubMed ID: 24510834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular DNA immunization with in vivo electroporation induces antigen-specific cellular and humoral immune responses in both systemic and gut-mucosal compartments.
    Shoji M; Katayama K; Tachibana M; Tomita K; Sakurai F; Kawabata K; Mizuguchi H
    Vaccine; 2012 Nov; 30(50):7278-85. PubMed ID: 23036499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle.
    Lin F; Shen X; McCoy JR; Mendoza JM; Yan J; Kemmerrer SV; Khan AS; Weiner DB; Broderick KE; Sardesai NY
    Vaccine; 2011 Sep; 29(39):6771-80. PubMed ID: 21199706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection site-dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination.
    Guan X; Nishikawa M; Takemoto S; Ohno Y; Yata T; Takakura Y
    J Gene Med; 2010 Mar; 12(3):301-9. PubMed ID: 20084616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.